Why your father's LIC policy is hurting you.

In a typical Indian doctor's financial file, somewhere among the policies, there is at least one insurance plan that was bought before the doctor was old enough to read it. A father, an uncle, or an early career mentor took it out in the doctor's name, paid the first few premiums, and over time handed over the policy. The doctor inherits it. They have a vague sense of what it does. They continue paying the premium because it has always been there. This is, in our experience, the single most under-examined item on most doctors' personal balance sheets.

These legacy policies have a few things in common.

• They were sold by a family acquaintance — an LIC agent, a banker, a friend's father — at a time when distribution incentives, not the policyholder's interest, drove the recommendation.
• They are usually some variant of an endowment plan, money-back policy, or whole-life cover. Almost never a pure-term policy.
• They have a small face value, an even smaller "bonus", and a multi-decade term. Premiums are typically modest in absolute terms but cumulatively meaningful.
• The IRR, calculated honestly, is somewhere between 4% and 5.5% — meaningfully below the post-tax return of every reasonable alternative.

The actual cost of keeping them

The annual premium on a single legacy endowment plan is often modest — say ₹40,000 a year. The doctor, evaluating it casually, may decide it is small enough not to worry about. In isolation, this is reasonable.

The trouble is that most doctors hold three to six such policies. Cumulatively, the annual premium can run to ₹2-4 lakh — money that, if redirected into a balanced portfolio, would have compounded into a meaningful additional ₹5-15 crore over the doctor's career.

The visibility problem is structural. Each policy is small, each is paid by auto-debit, each comes with sentimental anchoring. The doctor never adds them up.

Why they are so hard to exit

The financial argument is clear. The reasons doctors keep these policies in force, despite the economic case to exit, are deeply non-financial.

1. Surrender losses. Endowment plans, surrendered before maturity, return less than the cumulative premiums paid. The doctor sees the surrender value, calculates the "loss", and decides to continue paying. This is a sunk-cost reflex; the alternative — continuing to pay below-market returns for another 15 years — is also a loss, but a hidden one.

2. The agent relationship. The agent is a family contact. Surrendering the policy feels like a personal slight. Many doctors continue policies they intellectually understand are bad, simply to avoid the awkward conversation with someone who has been a steady presence at their family's events.

3. Sentimental association. The policy was the father's gesture. Surrendering it feels like a dishonouring of the father's intent. The father, almost always, intended only the doctor's financial well-being — and would, if asked, prefer the doctor be financially well-off rather than carry their misallocated decision forever. But the question is rarely framed this way.

4. Asymmetric loss aversion. The doctor over-weights the visible surrender loss versus the invisible opportunity cost. This is a normal human bias. It is also, when added up across multiple policies and a 25-year horizon, materially expensive.

The framework for re-evaluation

We work through legacy policies with a structured exercise.

• List every policy in force. Date of issue, sum assured, current premium, current surrender value, projected maturity value, and remaining term.
• Calculate the IRR, run cleanly. What return is the policy actually producing, given the cash flows so far and projected, after the implicit cost of insurance?
• Compare the IRR to the realistic alternative. A balanced equity-debt mutual fund portfolio over the same horizon, post-tax.
• Calculate the insurance gap. If these policies were surrendered, what cover would be lost? Is there sufficient pure-term cover to compensate? If not, layer in additional term first.
• Make the decision policy-by-policy. Some legacy policies, particularly older whole-life policies bought at favourable rates, may genuinely be worth keeping. Many are not. The decision should be specific.

The right sequence

A common mistake is to try to exit all legacy policies in a single move. We advise against this. The right approach is staggered:

• Year 1: Buy adequate term cover at the doctor's current life-stage. Confirm health and indemnity adequacy.
• Year 2: Surrender the worst-performing legacy policies — usually the ones with the lowest IRR and the smallest sum assured.
• Year 3-4: Surrender the next tier, monitoring tax treatment of surrender values where applicable.
• Year 5+: Hold the few policies that are genuinely worth keeping.

The staggered approach keeps the family covered, preserves relationships where it matters, and avoids the perception of hasty action.

The conversation with the agent

The hardest part is the conversation. We have found a useful framing.

"I am restructuring my insurance portfolio with the help of an independent advisor. As part of the restructuring, I will be surrendering some older policies and increasing my term cover. I appreciate everything you've done for our family — and would like your help in making the transition as clean as possible."

This phrasing acknowledges the relationship, takes ownership of the decision, and avoids litigating each policy individually. The agent, in our experience, almost always accepts it gracefully. Some agents even thank the doctor for being clear; the truth is they have many clients whose policies they themselves know are sub-optimal.

The plain version

Legacy insurance policies are a classic small-tax problem — small enough to ignore individually, costly enough cumulatively. Reviewing them with discipline is a one-time exercise that produces a one-time correction. After that, the doctor's protection portfolio is what they themselves have chosen, sized to their actual life, and structured to pay for what it should pay for. No more, no less.